Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Haiti Health Town Hall Calls for Progress Against Malaria


The Haitian diaspora is critical to advocate for stronger healthcare policy and investment across Haiti.

The Haiti Renewal Alliance (HRA) in partnership with the United Nations Foundation and the Embassy of Haiti will host a Haiti Health Town Hall focused on the fight against malaria, a preventable illness that threatens half the world’s population and kills a child every two minutes. Haiti and the Dominican Republic are the last malaria-endemic countries in the Caribbean, though targeted intervention has cut transmission rates there dramatically.

The town hall, “Integrating the Diaspora to Advance Community Health and Malaria Elimination Initiatives in Haiti,” will feature a conversation among public and private sector leaders exploring new thinking in malaria elimination. The Haitian diaspora is critical to advocate for stronger healthcare policy and investment across Haiti. The event, in conjunction with the United Nations Foundation’s Nothing But Nets campaign Leadership Summit, will highlight sustainable solutions to end malaria for good.

WHEN: 8:30 a.m. – 2:30 p.m. Wednesday, March 11

WHERE: Embassy of Haiti, 2311 Massachusetts Ave NW, Washington, DC 20008

WHO: U.S. and Haitian health officials, non-profit leaders, advocates, and healthcare providers

REGISTER: http://www.haitirenew.org/townhall

About Nothing But Nets

Nothing But Nets is the world’s largest grassroots campaign to save lives by preventing malaria. Nothing But Nets has raised over $70 million to help deliver more than 13 million bed nets and other crucial malaria interventions to families. In addition to raising funds for UN partners, Nothing But Nets raises awareness and voices to advocate for critical malaria funding for the UN, the U.S. President’s Malaria Initiative, and The Global Fund to Fight AIDS, Tuberculosis and Malaria as well as collaborates with the Malaria Zero Alliance to support malaria elimination efforts in Hispaniola. Learn more Nothing But Nets’ work in Haiti at http://nothingbutnets.net.

About Haiti Renewal Alliance (HRA)

HRA is a non-profit organization that promotes sustainable development and investment in Haiti. HRA facilitates innovative development strategies and planning throughout the Caribbean and within its Diaspora communities by leveraging financial, human, and social capital to support economic development. Learn more at http://haitirenew.org.

About The United Nations Foundation

The United Nations Foundation connects people, ideas, and resources to the UN to deliver a better world for all. Founded in 1998 by entrepreneur and philanthropist Ted Turner, the UN Foundation works with philanthropic, corporate, government, and individual partners across various strategic initiatives, campaigns, and alliances. The United Nations Foundation has invested in Haiti’s acceleration to achieve its Sustainable Development Goals by supporting the country’s journey towards malaria elimination through its global malaria campaign Nothing But Nets. Learn more at http://unfoundation.org.

Share article on social media or email:

Palo Alto University Presents: Superstar Psychologists in Technology


On March 19, 2020, from 5:30 p.m. to 7:30 p.m. PST, Palo Alto University will host Superstar Psychologists in Technology, a psychology workshop featuring a presentation from Sam Jaffee, User Experience Researcher at Google. This event will be sponsored by Palo Alto University Research Professor C. Barr Taylor, m2Health, i4Care and Behavioral Intervention Technologies (BITS) student group.

Sam Jaffee attended Bowling Green State University, where he received his Ph.D. in Experimental Psychology and also studied motion perception and spatial problem-solving in digital environments. Following his completion of the Ph.D. program, Jaffee worked as a User Experience Researcher at Capital One for two years, supporting various credit-related products. His career at Google began after a one-year stint at Alma College, where he took a visiting professorship. In his work with Google, Jaffee’s work focuses on improving mobile keyboards.

Outside of his current work, Jaffee has a passion for teaching and hopes to utilize his experiences from the applied world to improve the academic experiences of students inside and outside of psychology and the social sciences.

The event will take place at the Palo Alto University E-Clinic Suite C15A, at the Los Altos campus. Maureen O’Connor, Ph.D., J.D., president of Palo Alto University, will moderate the event. Dr. Jaffee’s presentation will be preceded by a reception that will include light refreshments and food. President O’Connor is excited to welcome Jaffee to speak at this event and stated, “Palo Alto University celebrates professionals that pave the way for innovation in psychology. Jaffee’s technological expertise is exactly what we’d like to share with others working toward advancing in the field.”

To learn more about this opportunity and other available psychology and business workshops, interested parties can register to attend the event virtually by joining via ZOOM. For more information, visit http://www.paloaltou.edu or call 650-433-3828. The Palo Alto University campus is located at 1791 Arastradero Road, Palo Alto, CA 94304.

Palo Alto University is dedicated to improving the human condition through excellence in teaching, research and scholarship in the fields of psychology and counseling. With an unwavering commitment to diversity and to the communities it serves, PAU offers doctorate, master’s and bachelor’s programs, as well as hands-on clinical training. A private, non-profit university, PAU is accredited by the Western Association of Schools and Colleges. Connect at: http://www.paloaltou.edu

Share article on social media or email:

Former FDA Commissioner Explains Growing Opportunities for Biomedical Products Webinar, Mar. 19, 2020


WCG FDANews

WCG FDANews

Healthcare Innovation and FDA Regulation

Former FDA Commissioner Explains Growing Opportunities for Biomedical Products

An FDAnews Webinar

Thursday, March 19, 2020 • 11:00 a.m.-12:00 p.m. EDT

https://www.fdanews.com/healthcareinnovation

With an unprecedented number of new, potentially transformative health technologies coming to market in the U.S., there are growing calls to better align the evidence generation that supports regulatory submission and the payment effort that informs patient use and access. Understand the intersection of healthcare innovation and FDA regulation and one will have what one needs to come out on top of this revolution.

Who better than to bring attendees up to speed on the latest developments and trends in this arena than a former FDA Commissioner? Mark McClellan, MD, PhD is currently the Robert J. Margolis Professor of Business, Medicine and Health Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University. Dr. McClellan will share:


  • An overview of emerging trends in medical product development, including efforts to further improve development and regulatory review
  • The overall landscape of value-based payment and delivery reforms, and what one must know about their growing linkages to medical product development
  • Increasing concerns associated with the price for transformative medical technologies like gene and cell therapies, and how these anticipated prices are driving stakeholders to explore new types of contract mechanisms and alternative payment models
  • Insight into new policy development areas emerging around challenges with payer coding, coverage and payment processes for innovative medical technologies
  • The growing need for a real-world data and evidence-development infrastructure and its anticipated role in improving your development of medical products as well as regulation and care delivery

If one wants to increasingly provide the right treatments and interventions to the right patients at the right time in this changing landscape of transformative health technologies, you must listen to Dr. McClellan explain the intersection of healthcare innovation and FDA regulation.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.

Webinar Details:

Healthcare Innovation and FDA Regulation

Former FDA Commissioner Explains Growing Opportunities for Biomedical Products

An FDAnews Webinar

Thursday, March 19, 2020 • 11:00 a.m.-12:00 p.m. EDT

https://www.fdanews.com/healthcareinnovation

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/healthcareinnovation

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

AsSeenOnTV.pro and Kevin Harrington’s DRTV Campaign with The Cats Meow CBD


Interest in CBD is rising, as is its list of potential benefits. Research shows CBD may improve a variety of conditions, both mentally and physically. The Cats Meow CBD offers full-spectrum and THC-free CBD products for the whole family.

Healthcare professional owned, The Cats Meow CBD wants to help you experience all of the potential benefits that CBD has to offer in order to help you thrive. They offer a variety of absorption methods, so you can choose what’s best for you. The Cats Meow CBD products are organic, non-GMO, non-psychoactive, and free from solvent and metals. They’re also lab-tested, for quality and safety. Their all-natural line of wellness and beauty products aims to enhance the quality of life for you and your loved ones. The Cats Meow CBD is the purrfect blend of CBD wellness and beauty products.

“As a healthcare practitioner and chronic illness warrior, I know the value and importance of high quality products,” says Heather Green, CEO of The Cats Meow CBD. “Here at The Cats Meow CBD, we would never sell a product we would not use ourselves or for our family. We’re always transparent with our lab work and pride ourselves on providing the best quality product. That’s why we partnered with AsSeenOnTV.pro and trust that doing so will help expand our audience even further.”

“The Cats Meow CBD products are amazing,” says Douglas Scott, Executive Producer at AsSeenOnTV.pro. “Not only do they offer products for people and pets, but the education they provide their customers with really makes them stand out.”

.

As part of its DRTV campaign with AsSeenOnTV.pro, The Cats Meow CBD has appeared in 60 second spots nationwide, featuring the original Shark himself, Kevin Harrington. AsSeenOnTV.pro is comprised of an award-winning team of producers, writers, videographers, and editors as well as industry veterans dedicated to finding the latest, most innovative products and ideas, and putting them on the DRTV map.

About AsSeenOnTV.pro

Headquartered in South Florida, AsSeenOnTV.pro is a full-service production, branding, and marketing company that specializes in direct response television, short- and long-form commercials, and brand building. Based out of a 25,000+ sq ft, state-of-the-art studio, the company’s creative team handles every aspect of production from script to screen to airing. For nearly two decades, AsSeenOnTV.pro’s veteran staff of writers, producers, videographers, and editors has amassed more than 50 Telly Awards, thousands of prestigious clients, and over $20 million in television placements.

About Kevin Harrington

As the inventor of the infomercial, founder of As Seen on TV, and one of the original Sharks on Shark Tank, Kevin Harrington has worked with some of the world’s biggest celebrities and launched some of the best-selling DRTV campaigns in history. Since producing his first 30-minute infomercial in 1984, Harrington has been involved in over 500 product launches that have resulted in over $4 billion in sales. Now, in his latest venture with AsSeenOnTV.pro, Harrington is on the hunt for the best new products and ideas, bringing them to homes everywhere through personalized DRTV campaigns featuring the Shark.

For more information on The Cats Meow CBD, please visit http://www.thecatsmeowcbd.com.

Share article on social media or email:

Ali Landry, founder of RE/SHAPE, Appears on “The Doctors” to Share How Regenerative Cell Therapy From Beverly Hills Rejuvenation Center® Has Helped Her Retain Her Youth


Beverly Hills Rejuvenation Center and Ali Landry’s Results

When I saw the side by side, I’m not kidding you, I almost fell out of my chair. – Ali Landry

Ali Landry, founder of RE/SHAPE, appeared on the popular syndicated talk show, “The Doctors,” on February 24 to discuss a cutting-edge therapeutic service, regenerative cell therapy, that she has been receiving from Beverly Hills Rejuvenation Center®, the premier medical spa for health and beauty.

From age rejuvenation treatments like facial wrinkles, hair loss and sexual health to wellness procedures for joint repair, sport injuries and rapid recovery, the Regenerative Cell Therapy services are offered at select Beverly Hills Rejuvenation Center® locations.

Landry has been going to Beverly Hills Rejuvenation Center®’s Regenerative Cell Therapy treatment to helping her cope chronic pain, which she believes stems from a car accident she had 20 years ago. The Regenerative Cell Therapy is able to detect damaged joint cartilage and then offers targeted injections that can potentially treat arthritis.

But as the world learned on “The Doctors,” Landry has also been going to BHRC to keep her skin looking young.

As she says on “The Doctors,” in a segment where they show her receiving a Regenerative Cell Therapy treatment, “I just turned 46 years old, and everything seems to have changed.”

After the segment, in the studio audience, the hosts showed a “before” and “after” photo of Landry, demonstrating what a Regenerative Cell Therapy treatment can do.

Landry, who is also a mother of three, actress and a former Miss USA, told the hosts and audience, “When I saw the side by side, I’m not kidding you, I almost fell out of my chair.”

Beverly Hills Rejuvenation Center’s regenerative products are FDA-compliant human cell and tissue products (HCT/P) and sourced from the rich Wharton’s Jelly layer of the umbilical cord and amniotic fluid and amino tissue from healthy, full term donors.

The Beverly Hills Rejuvenation Center® offers an array of aesthetic and beauty procedures that range from injectables, laser hair removal, facials as well as anti-aging, hormones and wellness treatments. The board-certified, expert staff utilizes state-of-the-art equipment and the highest quality products for each of the different treatments that deliver visible results.

Consults for health, wellness and beauty treatments are always complimentary at the Beverly Hills Rejuvenation Center®. To schedule a consultation or for more information, please visit us online at http://www.bhrcenter.com.

As one of the few medical spa franchises available in the U.S., the Beverly Hills Rejuvenation Center® business model has been the perfect diversification plan for seasoned entrepreneurs and physicians seeking a cutting edge offering in a rapidly growing market that currently exceeds $15 billion/year. For more information about franchise opportunities, please call us at (310) 473-5800 or visit https://bhrcenter.com/medspa-franchise.

ABOUT BEVERLY HILLS REJUVENATION CENTER®

For more than 15 years, Beverly Hills Rejuvenation Center®, has been the leader in the aesthetic and wellness industries for their innovative elite health and wellness programs, customizing anti-aging therapies, cutting-edge technologies, and seasoned team of industry professionals. Currently, BHRC operates 16 locations in key markets including Los Angeles, Newport Beach, Las Vegas, Scottsdale, Dallas, San Antonio, Austin, Boca Raton and now Houston.

Share article on social media or email:

Self-Funding Expert, Lynn Stetson, Named New Senior Account Executive of National Client Management at Health Plans, Inc. (HPI)


Springing forward after another successful year of growth, HPI has named Lynn Stetson as senior account executive of national client management. Lynn has spent over 25 years in the self-funded health plan industry and has dedicated her career to building trusting and lasting relationships with clients and their consultants. Her expertise will continue to fuel HPI’s development outside of New England as she provides exceptional service and educates customers about self-funding.

“I am thrilled to welcome Lynn to HPI’s national team,” said Holly Weiske, vice president of national client management at HPI. “Lynn’s exceptional leadership and communication skills surely will have a great impact as we continue to cultivate our customer relationships throughout the country.”

Stetson most recently served as a senior account executive at Lucent Health (formerly Cypress Benefit Administrators) for which responsibilities included client relations, renewals, and product and strategic consulting. Previously, she served as a client relationship manager at Meritain Health.

“I am thrilled to be part of a nationally growing company that is committed to successful relationships, outstanding service and innovation,” said Stetson. “I bring a wealth of knowledge to my client relationships, and my experience in working on all sides of the self-funded health plan industry will help take HPI to the next level.”

About HPI

HPI redefines what is possible with self-funded health plans. As a third-party administrator, we partner with health plan brokers and employers to provide innovative self-funding strategies and customized plans tailored to each client’s needs and population. Our solutions give employers greater cost transparency and control, while elevating the member experience. It is our flexible approach, entrepreneurial spirit and commitment to quality, technology, and service that enable us to deliver premium value to our customers.

For more information, visit http://www.healthplansinc.com.

MEDIA CONTACT:

Su Doyle, Director of Strategic Marketing

Health Plans, Inc.

508-475-6103

sdoyle@healthplansinc.com

Share article on social media or email:

Applications now Open for 2020 IGNITE


MassMEDIC MedTech IGNITE is now accepting applications from medtech startup founders and CEOs for the 2020 Cohort. Apply by March 31st at https://www.ignitemedtech.com/

“With a larger Steering Committee of industry leaders, additional faculty of experts and new training programs added, IGNITE 2020 will be a banner year for our program. IGNITE has consistently attracted the rising stars in MedTech and we encourage startup founders to apply and join the community.”

The Massachusetts Medical Device Industry Council (MassMEDIC) encourages medtech startup founders and CEOs to apply to the MedTech IGNITE program’s 2020 IGNITE Cohort. The MedTech IGNITE Program is a virtual accelerator offering an experiential training, mentorship and networking curriculum to attract and nurture the next generation of medtech founders and entrepreneurs. IGNITE Cohort members get access to medtech, financial, business and legal experts and advisors to help them succeed.

IGNITE was relaunched in 2019 with a cohort of 16 companies and support from a grant from the Massachusetts Life Sciences Center. The 2019 Cohort includes MassChallenge winner Azadeh Khanicheh of Envision Endoscopy and BRIght Future Prize winner Natalie Artzi of BioDevek. Seven of the 16 founders in the 2019 Cohort founders were women

“With a larger Steering Committee of industry leaders, additional faculty of experts and new training programs added, IGNITE 2020 will be a banner year for our program,’” said Brian Johnson, President of MassMEDIC. “IGNITE has consistently attracted the rising stars in MedTech and we encourage startup founders to apply and join the community.”

Benefits of participating in the 2020 IGNITE Cohort include:

  • Potential prizes of up to $70,000 in cash and services to select 2020 Cohort members
  • Unparalleled Master Classes and training sessions led by legal, financial, business, entrepreneurial, design and medtech experts and professors
  • Exclusive pitch opportunity to senior leaders at MedTech’s top companies
  • Access to industry thought leaders in intimate, invite-only gatherings
  • One on one industry expert mentoring
  • Networking and introductions to strategics, mentors and advisors
  • Complimentary membership to MassMEDIC for one year
  • Discounted and complimentary access to premier medtech events
  • Publicity and awareness for selected ventures
  • Opportunity to present at DeviceTalks MedTech Showcase

To join the MedTech IGNITE Community and to apply for the 2020 Cohort by the March 31st deadline, visit: https://www.ignitemedtech.com/ and click on Go to Challenge

Share article on social media or email:

NutraPak USA Announces Major Expansion into Sports Nutrition Packaging


Sports nutrition packaging

Sports nutrition packaging

As growth in the sports nutrition segment outpaces traditional vitamins and minerals, NutraPak USA has invested in new, state-of-the-art production lines for large jars, packers and canisters to meet the needs of this image-conscious market.

NutraPak USA, a leading U.S. packager of nutritional supplements, has announced today a major investment into the sports nutrition category. According to Brandon Miller, President of NutraPak USA, “as growth in the sports nutrition segment outpaces traditional vitamins and minerals, NutraPak USA has invested in new, state-of-the-art production lines for large jars, packers and canisters to meet the needs of this image-conscious market.” They also carry a full line of private label sports nutrition supplements including whey protein, pre-workout powders, and recovery health vitamins.

The company now offers the most complete line of large indented PET packers in the industry, including sizes from 1500cc (48oz) to 6250cc (1.6 gallons) with several gram weight options and consumer-friendly powder scoop designs for ease of use and reduced mess. NutraPak USA also has the industry’s lowest minimum order quantities, including for custom colors, shapes and sizes. Innovative packaging with custom-design labeling reflects an awareness that sports nutrition products are examples of “on show” products left on display by consumers.

NutraPak USA sources its ingredients from around the world emphasizing high product quality and consistency, produced in accordance with HACCP, GMP, USDA Organic and ISO 9001 certifications. The company provides quality private-label packaging for softgels, gelcaps, caplets, tablets and capsules in plastic bottles, blister packs or pouches, and liquids in glass or plastic bottles or tinctures, utilizing a wide variety of caps, pumps, droppers, and seals. They’re known for their high level of customer care and extremely competitive pricing for private label retailers and contract manufacturers in the United States and overseas.

NutraPak USA is strongly committed to providing its customers with green, eco-friendly, sustainable packaging. Their fully-green option gives clients a strong marketing advantage with environmentally-conscious consumers.

The company offers a comprehensive program of services, turnkey solutions, and client support that exceeds industry standards. Their product development team can provide customized, proprietary formulations designed specifically to meet the needs of their customers and their customers’ methods of distribution. NutraPak USA’s vertically integrated manufacturing and packaging process allows them to schedule flexible production runs to respond quickly to shifting market conditions and new consumer demand.

In addition to servicing the largest brand marketers and retail chains, NutraPak USA has a strong commitment to assisting startups with small runs, full package design services, and one-stop shopping to quickly and competitively launch new products. They are also the go-to provider for the burgeoning pet supplement market.

Share article on social media or email:

Dr. Catherine DiGiorgio Joins the Team at the Boston Center for Facial Rejuvenation


Dr. Catherine DiGiorgio joins Boston Center for Facial Rejuvenation

Dr. Catherine DiGiorgio joins Boston Center for Facial Rejuvenation

Leonard Miller, MD, FACS, FRCS is happy to announce the arrival of Board-Certified Dermatologist, Catherine DiGiorgio, MD. The Harvard-trained dermatologist comes into the group with a top-notch education and extensive experience in lasers and cosmetic procedures, most recently working in private practice in Boston, MA and Austin, TX. The Boston Center for Facial Rejuvenation is pleased to add Dr. DiGiorgio’s unique dermatology expertise and skill to the aesthetic team.

And replace with “Dr. Miller started his private practice in 1985 and over the last 20 years has built the Boston Center for Facial Rejuvenation into a leading cosmetic surgical and non-surgical treatment facility for the greater Boston area. A pioneer in the field of aesthetic medicine, he was the first doctor to bring the micro-needling procedure to the United States. A board-certified plastic surgeon, over the years, Dr. Miller has perfected several innovative and complex surgical techniques such as the natural facelift and neck rejuvenation. Dr. Miller continues to participate in valuable clinical trials, developing new cosmetic products and skin care technologies.

Dr. Doherty is a board-certified plastic surgeon, specializing in surgical procedures for the breast and body. He joined the Boston Center for Facial Rejuvenation in February of 2015, bringing his talent for creating a pleasing appearance without looking plastic or unnatural. Together, Dr. Miller and Dr. Doherty have been able to provide a wide range of cosmetic surgery procedures for all areas of the face, neck, breast and body.

With two locations, one in Boston and one in Brookline, the Boston Center for Facial Rejuvenation has grown into one of the city’s top destinations for surgical and noninvasive cosmetic procedures. As a board-certified dermatologist, Dr. DiGiorgio will bring extensive experience, sharing the team’s passion for gentle, natural aesthetic care. She is already an active member of the Boston community and will make an outstanding addition to the Boston Center for Facial Rejuvenation team.

ABOUT DR. CATHERINE DIGIRGIO

The New Orleans native completed her medical training at the Tulane University School of Medicine. This was followed by her internship in Internal Medicine and residency in Dermatology at Louisiana State University Health Sciences Center. Dr. DiGiorgio came to Boston for a competitive fellowship, training at the Harvard Laser and Cosmetic for Photomedicine for 2 years. During this time, she trained in the application of laser and energy-based devices alongside the world’s most respected dermatologists. Today, Dr. DiGiorgio is a speaker and educator, presenting at medical conferences across the U.S., contributing to peer-reviewed journals and textbooks, and participating in dermatology resident education. Before coming to the Boston Center for Facial Rejuvenation, Dr. DiGiorgio practiced dermatology in private practice in Boston and Austin, Texas.

Known for using a conservative approach to dermatology, Dr. DiGiorgio creates a unique treatment plan for every individual. With a gentle bedside manner, she tailors each plan around the patient’s needs, goals and lifestyle. Dr. DiGiorgio specializes in the use of lasers for semi-invasive and noninvasive procedures. She has extensive experience with Botox and fillers, thread lifts, and microneedling, as well as using PRP growth factors for restoring both skin and hair.

The Boston Center for Facial Rejuvenation welcomes all our patients to consult with Dr. DiGiorgio. She is going to make a wonderful addition to the team. If you would like more information on any of our anti-aging treatments or would like to schedule a consultation appointment with Dr. DiGiorgio, contact the Boston Center for Facial Rejuvenation at 617.735.8735.

Share article on social media or email:

VGXI Recognized as Best CMO Finalist for the 2020 Vaccine Industry Excellence Awards


News Image

VGXI’s nomination for Best CMO is a testament to our company’s reputation among industry leaders, our clients, and our partners.

VGXI, Inc., a uniquely specialized CDMO providing high quality plasmid DNA-based products and services, announced it has been nominated as a finalist in the category of Best Contract Manufacturing Organization for the annual Vaccine Industry Excellence (ViE) Awards. This nomination comes as VGXI expedites manufacturing of a DNA vaccine against the novel coronavirus, COVID-19, under a CEPI funded collaboration.

The ViE Awards highlight the accomplishments and positive contributions of companies and individuals across the vaccine industry. Shortlisted finalists for each of the 12 award categories are determined by industry nominations and voting over a 3 month period. The ViE Scientific Advisory Board oversees the final judging round.

“VGXI’s nomination for Best CMO is a testament to our company’s reputation among industry leaders, our clients, and our partners,” stated VGXI COO Dorothy Peterson. “With nearly 20 years of experience, we have established a track record of success in delivering exceptional results for our client’s challenging projects.”

As part of the annual World Vaccine Congress in Washington DC, winners in each category will be announced at the ViE Awards Ceremony & Gala Dinner on April 7th, 2020.

VGXI will also be exhibiting at Booth #310 during the WVC conference. Requests for partnering meetings during the event are welcome and can be submitted at the VGXI website: http://vgxii.com/contact-us/

ABOUT VGXI, INC.

VGXI, Inc. is a leading provider of manufacturing and development services for DNA vaccines and gene therapies. The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. VGXI, Inc. is a wholly-owned subsidiary CDMO of GeneOne Life Science, Inc. To learn more, visit http://www.vgxii.com.

ABOUT GENEONE LIFE SCIENCE

GeneOne Life Science Inc. (“GeneOne” KOSPI: 011000) is an international DNA vaccine and product developer, and leading contract manufacturer of DNA plasmid-based agents for pre-clinical and clinical trials for global companies and institutions. It researches and develops DNA vaccines and products to prevent and treat incurable diseases in South Korea and internationally. The company is headquartered in Seoul, South Korea. VGXI, Inc., GeneOne’s wholly-owned manufacturing subsidiary located in Texas, is the largest pure-play cGMP DNA plasmid manufacturing facility in the world. For more information, visit http://www.genels.com/en.

CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS

Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

Share article on social media or email: